225 related articles for article (PubMed ID: 25855582)
81. [Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
Wang S; Gao H; Zhang J; Ye X
Se Pu; 2017 Sep; 35(9):934-940. PubMed ID: 29048850
[TBL] [Abstract][Full Text] [Related]
82. The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.
Block TM; Marrero J; Gish RG; Sherman M; London WT; Srivastava S; Wagner PD
Cancer Biomark; 2008; 4(1):19-33. PubMed ID: 18334731
[TBL] [Abstract][Full Text] [Related]
83. Diagnosis of primary hepatocellular carcinoma.
Tong MJ
Gastroenterology; 1986 Nov; 91(5):1306-7. PubMed ID: 2428693
[No Abstract] [Full Text] [Related]
84. Update on biomarkers of hepatocellular carcinoma.
Chaiteerakij R; Addissie BD; Roberts LR
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
[TBL] [Abstract][Full Text] [Related]
85. Emerging evidence of molecular biomarkers in hepatocellular carcinoma.
Umeda S; Kanda M; Kodera Y
Histol Histopathol; 2018 Apr; 33(4):343-355. PubMed ID: 28959824
[TBL] [Abstract][Full Text] [Related]
86. DETECT: Development of Technologies for Early HCC Detection.
Benhammou JN; Rich NE; Cholankeril G; Zhang P; Zeng W; Rao S; Tayob N;
Gastroenterology; 2022 Jul; 163(1):21-27. PubMed ID: 35339460
[No Abstract] [Full Text] [Related]
87. State-of-the-art Hepatocellular Carcinoma Biomarker Detection by Biosensor Technology-a Review.
Uygun ZO
J Gastrointest Cancer; 2021 Sep; 52(3):1081-1085. PubMed ID: 34347247
[TBL] [Abstract][Full Text] [Related]
88. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.
Cerrito L; Ainora ME; Mosoni C; Borriello R; Gasbarrini A; Zocco MA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230569
[TBL] [Abstract][Full Text] [Related]
89. Biomarkers for early diagnosis of hepatocellular carcinoma.
Forner A; Bruix J
Lancet Oncol; 2012 Aug; 13(8):750-1. PubMed ID: 22738800
[No Abstract] [Full Text] [Related]
90. The BALAD-2 and GALAD biomarker models for hepatocellular carcinoma.
Johnson PJ
Clin Adv Hematol Oncol; 2017 Jun; 15(6):452-454. PubMed ID: 28749905
[No Abstract] [Full Text] [Related]
91. Dickkopf-1 and hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang WL
Lancet Oncol; 2012 Oct; 13(10):e410; author reply e410-1. PubMed ID: 23026825
[No Abstract] [Full Text] [Related]
92. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma.
Song T; Li L; Wu S; Liu Y; Guo C; Wang W; Dai L; Zhang T; Wu H; Su B
Front Oncol; 2021; 11():583714. PubMed ID: 33777736
[TBL] [Abstract][Full Text] [Related]
93. Pitfalls in the interpretation of tumour markers.
Oleesky DA; Fifield R
BMJ; 1996 Jan; 312(7024):183. PubMed ID: 8563553
[No Abstract] [Full Text] [Related]
94. Early detection of hepatocellular carcinoma through surveillance using biomarkers.
Gish RG
Gastroenterol Hepatol (N Y); 2014 Feb; 10(2):121-3. PubMed ID: 24803876
[No Abstract] [Full Text] [Related]
95. Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.
Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
Hepatogastroenterology; 2015; 62(138):399-404. PubMed ID: 25916071
[TBL] [Abstract][Full Text] [Related]
96. Guide for diagnosis and treatment of hepatocellular carcinoma.
Attwa MH; El-Etreby SA
World J Hepatol; 2015 Jun; 7(12):1632-51. PubMed ID: 26140083
[TBL] [Abstract][Full Text] [Related]
97. Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma.
Cristea CG; Gheonea IA; Săndulescu LD; Gheonea DI; Ciurea T; Purcarea MR
J Med Life; 2015; 8(2):120-8. PubMed ID: 25866565
[TBL] [Abstract][Full Text] [Related]
98. Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma.
Kuczynski EA; Lee CR; Man S; Chen E; Kerbel RS
Cancer Res; 2015 Jun; 75(12):2510-9. PubMed ID: 25908587
[TBL] [Abstract][Full Text] [Related]
99. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis.
Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y
BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709
[TBL] [Abstract][Full Text] [Related]
100. Glypican-3 as a specific biomarker for hepatocellular carcinoma.
Yao M; Pan LH; Yao DF
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):122-3. PubMed ID: 25865682
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
